#DataM_Intelligence
Exploring the High-Growth Landscape of the Agentic AI Market and Its Transformation Across Industries#United_States#Austin#agentic_AI#DataM_Intelligence#Autonomous_Execution
Exploring the High-Growth Landscape of the Agentic AI Market and Its Transformation Across Industries
The Agentic AI market is projected to soar, reaching $98.26 billion by 2033, driven by demand for autonomous execution and enterprise software needs.
third-news.com
February 4, 2026 at 3:50 PM
Significant Growth in Deception Technology Market to USD 5.7 Billion by 2030 as Cyber Defense Evolves#USA#Austin#Cybersecurity#DataM_Intelligence#Deception_Technology
Significant Growth in Deception Technology Market to USD 5.7 Billion by 2030 as Cyber Defense Evolves
The Deception Technology Market is expected to reach USD 5.7 billion by 2030 as proactive strategies redefine cybersecurity defense approaches.
third-news.com
February 4, 2026 at 11:59 AM
Respiratory Syncytial Virus Market Expected to Surge to USD 4.54 Billion by 2033 with Innovative Vaccines and Antibody Developments#United_States#Austin#Monoclonal_Antibodies#RSV_Vaccine#DataM_Intelligence
Respiratory Syncytial Virus Market Expected to Surge to USD 4.54 Billion by 2033 with Innovative Vaccines and Antibody Developments
The Respiratory Syncytial Virus market is set to expand significantly, reaching USD 4.54 billion by 2033, driven by advanced vaccines and monoclonal antibodies for prevention.
third-news.com
December 1, 2025 at 3:17 PM
Prostate Cancer Drugs Market Expected to Reach $28.10 Billion by 2033, Driven by Innovative Therapies#United_States#Austin#Prostate_Cancer#Drug_Market#DataM_Intelligence
Prostate Cancer Drugs Market Expected to Reach $28.10 Billion by 2033, Driven by Innovative Therapies
The prostate cancer drugs market is projected to grow from $13.22 billion in 2024 to $28.10 billion by 2033, driven by advancements in therapies and increased demand.
third-news.com
November 21, 2025 at 3:23 PM
The Rising Demand for Floating Solar Panels: A Market Worth USD 84.90 Million by 2032#None#Floating_Solar#DataM_Intelligence#Utility-Scale
The Rising Demand for Floating Solar Panels: A Market Worth USD 84.90 Million by 2032
The floating solar panels market is set to grow significantly, reaching USD 84.90 million by 2032, driven by increasing utility-scale deployments across major global regions.
third-news.com
November 19, 2025 at 4:59 PM
DataM Intelligence Empowers Japanese Tech Firm in Asia-Pacific Minerals Market Growth#Japan#Tokyo#Critical_Minerals#DataM_Intelligence
DataM Intelligence Empowers Japanese Tech Firm in Asia-Pacific Minerals Market Growth
Explore how DataM Intelligence has enabled a Japanese engineering company to uncover key opportunities in the Asia-Pacific critical minerals sector.
third-news.com
October 28, 2025 at 5:10 PM
DataM Intelligence Drives Global Growth for Ingredient Manufacturer Through Strategic Market Insights#USA#Austin#Market_Expansion#Functional_Ingredients#DataM_Intelligence
DataM Intelligence Drives Global Growth for Ingredient Manufacturer Through Strategic Market Insights
Discover how DataM Intelligence helped a natural ingredient manufacturer expand globally through targeted customer identification and strategic planning.
third-news.com
October 16, 2025 at 9:54 AM
Bioresorbable Implants Market Forecasted to Reach US$14.34 Billion by 2033 Driven by Advances in Orthopedic and Cardiovascular Devices#United_States#Austin#Orthopedics#DataM_Intelligence#Bioresorbable_Implants
Bioresorbable Implants Market Forecasted to Reach US$14.34 Billion by 2033 Driven by Advances in Orthopedic and Cardiovascular Devices
The bioresorbable implants market is poised to double in size, reaching US$14.34 billion by 2033, fueled by innovations in orthopedic and cardiovascular applications that enhance surgical outcomes.
third-news.com
October 1, 2025 at 4:33 PM
Scleroderma Market Forecast: Growth Driven by Innovations in Biologics and Early Diagnosis#None#Biologics#DataM_Intelligence#Scleroderma
Scleroderma Market Forecast: Growth Driven by Innovations in Biologics and Early Diagnosis
DataM Intelligence projects the scleroderma market will expand from US$ 2.38 billion in 2024 to US$ 4.1 billion by 2033, fueled by advancements in treatment and diagnostics.
third-news.com
October 1, 2025 at 10:51 AM
RNA-Based Therapies Market Growth: Expected to Reach USD 213.54 Billion by 2033 Driven by Advances in Medical Technologies and Rare Disease Treatments#None#biotechnology#DataM_Intelligence#RNA-based_therapies
RNA-Based Therapies Market Growth: Expected to Reach USD 213.54 Billion by 2033 Driven by Advances in Medical Technologies and Rare Disease Treatments
The RNA-based therapies market is anticipated to grow to USD 213.54 billion by 2033, fueled by advancements in technology and rising demand for genetic and oncology treatments.
third-news.com
September 22, 2025 at 3:30 PM
Food Supplement Market Expected to Reach $345 Billion Driven by Health Trends and Innovations#USA#Austin#Preventive_Health#DataM_Intelligence#Food_Supplement
Food Supplement Market Expected to Reach $345 Billion Driven by Health Trends and Innovations
The Food Supplement Market, valued at $172.89 billion in 2022, is set to grow to $345.13 billion by 2031, reflecting rising awareness in preventive health.
third-news.com
September 8, 2025 at 2:55 PM